Compound information
- Natural Products
- ZC58742
- Molecular Formula
- C9H11NO4
- Molecular Weight
- 197.068807832 g/mol
- Structure
-
- IUPAC Name
- 5-(2,5-dioxopyrrol-1-yl)pentanoic acid
- InChI
- InChI=1S/C9H11NO4/c11-7-4-5-8(12)10(7)6-2-1-3-9(13)14/h4-5H,1-3,6H2,(H,13,14)
- InChI Key
- ACVAAFHNDGTZLL-UHFFFAOYSA-N
- SMILES
- O=C(O)CCCCN1C(=O)C=CC1=O
- Source
- ZINC000002527723
Warheads
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 14 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 74.68 Å2 | LogP | 0.967 |
LogS | -1.497 | LogD | -0.91 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.013 | Pgp substrate | 0.003 |
HIA | 0.901 | F20 % | 0.987 |
F30 % | 0.248 | Caco-2 | -5.119 |
MDCK | -4.655 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.997 | PPB | 76.779 |
VD | 0.507 | Fu | 0.6 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.016 | CYP1A2 substrate | 0.407 |
CYP2A6 substrate | 0.286 | CYP2B6 substrate | 0.406 |
CYP2C19 inhibitor | 0.037 | CYP2C19 substrate | 0.317 |
CYP2C8 substrate | 0.551 | CYP2C9 inhibitor | 0.011 |
CYP2C9 substrate | 0.029 | CYP2D6 inhibitor | 0.034 |
CYP2D6 substrate | 0.052 | CYP2E1 substrate | 0.348 |
CYP3A4 inhibitor | 0.007 | CYP3A4 substrate | 0.057 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.775 | CL | 2.717 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.07 | Hepatotoxicity | 0.245 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.052 |
FDAMDD | 0.114 | Skin Sensitization | 0.932 |
Carcinogenicity | 0.122 | Eye Corrosion | 0.01 |
Eye Irritation | 0.978 | Respiratory Toxicity | 0.011 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.126 | IGC50 | 2.059 |
LC50FM | 2.351 | LC50DM | 3.918 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.145 | NR-AR-LBD | 0.281 |
NR-AhR | 0.008 | NR-Aromatase | 0.085 |
NR-ER | 0.222 | NR-ER-LBD | 0.336 |
NR-PPAR-gamma | 0.831 | SR-ARE | 0.861 |
SR-ATAD5 | 0.506 | SR-HSE | 0.781 |
SR-MMP | 0.028 | SR-p53 | 0.412 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.